Share on StockTwits
 

Investment Analysts’ upgrades for Friday, January 24th:

Amphenol Corp. (NYSE:APH) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $106.00 target price on the stock. Zacks’ analyst wrote, “Amphenol reported stellar fourth quarter 2013 results with record earnings and revenues, comfortably beating the respective Zacks Consensus Estimates. Amphenol serves a variety of end markets, the diversification of which enables it to post strong results. Despite macroeconomic headwinds, Amphenol is bullish about the accelerating proliferation of new electronic products in most of its end markets, which it expects to propel demand with time. We are changing our long-term recommendation from Neutral to Outperform as we remain encouraged with the strong results of the company and its bullish guidance. However, cut-throat competition and foreign currency translation could undermine its growth potential to some extent. “

Apollo Group (NASDAQ:APOL) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. They currently have $42.00 price target on the stock. Zacks’ analyst wrote, “Despite declining 14.8% year over year, Apollo’s earnings of $1.04 in the first quarter of 2014 outpaced the Zacks Consensus Estimate by 15.6%. Significantly lower costs helped the company beat the earnings expectations despite weak revenues. Notwithstanding weak top-line and declining enrollment trends, the company raised its 2014 revenue, operating income and cost savings targets. In fact, management expects enrollment trends to improve throughout 2014. Apollo’s accelerated efforts to right-size its business through significant layoffs and campus closings will give it a competitive advantage in the long term. Apollo’s investments in adaptive learning, curriculum development, new learning systems/student service platforms and recent price cuts should improve student value proposition and retention rates. We believe these turnaround efforts should improve enrollment trends and boost margins in the future quarters. All these factors propelled us to upgrade our recommendation on Apollo from Neutral to Outperform. “

Ariad Pharmaceuticals (NASDAQ:ARIA) was upgraded by analysts at BMO Capital Markets to an outperform rating.

Allegheny Technologies (NYSE:ATI) was upgraded by analysts at Zacks from an underperform rating to a neutral rating. They currently have $35.00 price target on the stock.

Copa Holdings S.A. (NYSE:CPA) was upgraded by analysts at UBS AG from a sell rating to a neutral rating.

Delhaize Group (NYSE:DEG) was upgraded by analysts at Barclays from an equal weight rating to an overweight rating.

E.ON AG (NASDAQ:EONGY) was upgraded by analysts at Commerzbank AG from a reduce rating to a hold rating.

Fifth Street Finance Corp. (NYSE:FSC) was upgraded by analysts at National Securities from a neutral rating to a buy rating. The firm currently has $10.50 target price on the stock.

Forward Air Corp. (NASDAQ:FWRD) was upgraded by analysts at Avondale Partners from a market perform rating to an outperform rating.

HHGregg (NYSE:HGG) was upgraded by analysts at Standpoint Research from a hold rating to a buy rating. They currently have $16.00 price target on the stock.

Seagate (NYSE:STX) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. Zacks currently has $73.00 price target on the stock. Zacks’ analyst wrote, “We have upgraded our recommendation on Seagate to Outperform as we remain encouraged by the company’s significant exposure in the high-end corporate desktop and enterprise server markets. Moreover, the secular growth of digital data, modest growth in the TAM and higher demand for storage are expected to drive near-term results. Additionally, synergies from acquisitions and product innovations continue to drive growth. We believe that these factors will more than offset the lack of visibility in the HDD industry and difficult pricing environment.”

Synaptics (NASDAQ:SYNA) was upgraded by analysts at Feltl & Co. from a hold rating to a buy rating.

United Therapeutics Corp. (NASDAQ:UTHR) was upgraded by analysts at Zacks from a neutral rating to an outperform rating. Zacks currently has $135.00 price target on the stock. Zacks’ analyst wrote, “United Therapeutics is well-positioned to gain share in the pulmonary arterial hypertension (PAH) market. Lead product, Remodulin, continues to look very strong in both the IV and SC forms. Tyvaso and Adcirca should also contribute significantly to revenues as patient acceptance increases. Tyvaso’s performance has been improving and the product is on track to overtake Remodulin revenues in the next few quarters. Moreover, the recent approval of Orenitram is another milestone for the company. Given the company’s strong PAH portfolio and improving prospects, we are upgrading United Therapeutics to Outperform with a price target of $135. “

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.